Latest net income for MTP: $-10M, below the Healthcare sector average of $16B.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2025
Trailing 12 months ending Dec 2025
Loading...
Loading...
Midatech Pharma Plc (MTP) currently reports a net income of $-10M as of December 2025. That compares with $-6.9M in the prior-year period — down 50.3% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Midatech Pharma Plc's net income history and peer comparisons.
Midatech Pharma Plc's net income decreased from $-6.9M to $-10M — a 50.3% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Midatech Pharma Plc's net income of $-10M is lower than the Healthcare sector average of $16B. That is roughly 100.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
Midatech Pharma Plc reported $-10M in net income as of December 2025. That compares with $-6.9M in the prior-year period — down 50.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current net income of $-10M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Midatech Pharma Plc, and consider following MTP for alerts when major investors trade the stock.